Postpartum Depression Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

What market dynamics are playing a key role in accelerating the growth of the postpartum depression market?
The postpartum depression market is predicted to witness a surge due to an increasing number of cases of postpartum depression. Characterized by intense worry after childbirth, postpartum depression can present physical symptoms as well as mental ones. It often exists in tandem with postnatal depression and postpartum anxiety, with symptoms manifesting anytime within the first year after delivery. Treatment via psychotherapy, medication, or a combination of both, is common, contributing to market growth. For example, a survey by the University of Virginia School of Medicine (UVA SoM) conducted in February 2022, revealed that the risk of postpartum depression was highest in first-time mothers, those below 25, and mothers of twins. Among women between 18 to 24 years, 10% self-reported symptoms of postpartum depression. Mothers of twins had a higher rate at 11.3% compared to 8.3% in mothers with singletons. This rise in cases of postpartum depression is likely to boost the market. A surge in childbirths is also believed to fuel the postpartum depression market. Childbirth, the process of a baby's birth from the mother's uterus, typically via the vaginal canal, contributes to the prevalence of postpartum depression (PPD), a common condition affecting women post-childbirth. PPD can manifest as anxiety, sadness, fatigue, and issues bonding with the baby. For instance, a 2023 report from the Centers for Disease Control and Prevention highlighted a 1% increase in registered births in the United States, totaling 3,664,292 in comparison to the previous year. This upward trend in childbirths is anticipated to push the growth of the postpartum depression market.

Get Your Postpartum Depression Market Report Here:
https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

How will the growth rate of the postpartum depression market shape industry trends by 2034?
In the last few years, the market size for postpartum depression has experienced significant growth. The market size, which was $12.15 billion in 2024, is estimated to reach $16.09 billion in 2025, with a compound annual growth rate (CAGR) of 32.4%. Contributing factors to this growth in the historic period include heightened awareness of maternal mental health, advancements in research, initiation of public health programs, and augmented screening.

In the upcoming years, the market size of postpartum depression is anticipated to witness tremendous growth, expanding to a substantial $49.4 billion in 2029 with a compound annual growth rate (CAGR) of 32.4%. Factors attributing to the projected growth within this period are tied to the expansion of telehealth services, advancements in pharmacology, legislation for maternal mental health, and the growth of the mental health workforce. Significant trends for this forecasting period encompass the integration of care models, programs for peer support, perinatal mental health applications, and tools for mental health screening.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

What trends are poised to drive the future success of the postpartum depression market?
Companies within the postpartum depression market are focusing on introducing innovative products to maintain their market status. This is primarily due to the limited treatment options available, which have sparked an urgent requirement for swift, creative therapies and care delivery methods for managing postpartum depression. For example, Biogen Inc., a biotechnology company based in the United States, and Sage Therapeutics Inc., a US-based pharmaceutical company, announced in February 2023 that the FDA (Food and Drug Administration) in the United States acknowledged the submission of an NDA (new drug application) for the usage of zuranolone in treating major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone, a drug currently being tested, is a 14-day, fast-acting, once-daily oral therapy for people suffering from MDD and PPD. As a neuroactive steroid, it functions as a positive allosteric modulator of GABA-A receptors, offering a unique mode of operation. It is speculated to work within individuals dealing with depression by promptly recalibrating unbalanced neural networks, aiding in the restoration of normal brain function. Zuranolone is believed to influence the brain's networks that manage mood, arousal, behavior, and even cognition.

Which primary segments of the postpartum depression market are driving growth and industry transformations?
The postpartum depression market covered in this report is segmented -

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types
2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments
3) By Route of Administration: Oral, Parenteral, Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings
2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks
3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors
4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms
5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety
6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings
7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13024

Which geographical regions are pioneering growth in the postpartum depression market?
North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the influential players reshaping the postpartum depression market landscape?
Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

What Is Covered In The Postpartum Depression Global Market Report?

•Market Size Forecast: Examine the postpartum depression market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the postpartum depression market for a structured understanding.
•Key Players Overview: Analyze major players in the postpartum depression market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the postpartum depression market.
•Segment Contributions: Evaluate how different segments drive overall growth in the postpartum depression market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the postpartum depression market.
•Industry Challenges: Identify potential risks and obstacles affecting the postpartum depression market.
•Competitive Landscape: Review strategic developments in the postpartum depression market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.